Literature DB >> 16407265

Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix.

Elena Makareeva1, Wayne A Cabral, Joan C Marini, Sergey Leikin.   

Abstract

We demonstrate that 85 N-terminal amino acids of the alpha1(I) chain participate in a highly stable folding domain, acting as the stabilizing anchor for the amino end of the type I collagen triple helix. This anchor region is bordered by a microunfolding region, 15 amino acids in each chain, which include no proline or hydroxyproline residues and contain a chymotrypsin cleavage site. Glycine substitutions and amino acid deletions within the N-anchor domain induce its reversible unfolding above 34 degrees C. The overall triple helix denaturation temperature is reduced by 5-6 degrees C, similar to complete N-anchor removal. N-propeptide partially restores the stability of mutant procollagen but not sufficiently to prevent N-anchor unfolding and a conformational change at the N-propeptide cleavage site. The ensuing failure of N-proteinase to cleave at the misfolded site leads to incorporation of pN-collagen into fibrils. Similar, but weaker, effects are caused by G88E substitution in the adjacent triplet, which appears to alter N-anchor structure as well. As in Ehlers-Danlos syndrome (EDS) VIIA/B, fibrils containing pN-collagen are thinner and weaker causing EDS-like laxity of large and small joints and paraspinal ligaments. However, distinct structural consequences of N-anchor destabilization result in a distinct alpha1(I)-osteogenesis imperfecta (OI)/EDS phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407265     DOI: 10.1074/jbc.M511830200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Ehlers-Danlos Syndrome associated with cardiomyopathy hypertrophic obstructive.

Authors:  Raimundo José Almeida de Oliveira Pinto; Adaílton Araújo dos Santos; Mablo de Castro Azevedo; Saulo Sacramento Meira
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

Review 2.  Chaperoning osteogenesis: new protein-folding disease paradigms.

Authors:  Elena Makareeva; Nydea A Aviles; Sergey Leikin
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

3.  Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling.

Authors:  Lynn S Mirigian; Elena Makareeva; Sergey Leikin
Journal:  Connect Tissue Res       Date:  2014-09-22       Impact factor: 3.417

4.  Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates.

Authors:  Shawn M Sweeney; Joseph P Orgel; Andrzej Fertala; Jon D McAuliffe; Kevin R Turner; Gloria A Di Lullo; Steven Chen; Olga Antipova; Shiamalee Perumal; Leena Ala-Kokko; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini; James D San Antonio
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 5.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

6.  Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.

Authors:  Lynn S Mirigian; Elena Makareeva; Edward L Mertz; Shakib Omari; Anna M Roberts-Pilgrim; Arin K Oestreich; Charlotte L Phillips; Sergey Leikin
Journal:  J Bone Miner Res       Date:  2016-04-13       Impact factor: 6.741

7.  Vascular abnormalities in the placenta of Chst14-/- fetuses: implications in the pathophysiology of perinatal lethality of the murine model and vascular lesions in human CHST14/D4ST1 deficiency.

Authors:  Takahiro Yoshizawa; Shuji Mizumoto; Yuki Takahashi; Shin Shimada; Kazuyuki Sugahara; Jun Nakayama; Shin'ichi Takeda; Yoshihiro Nomura; Yuko Nitahara-Kasahara; Takashi Okada; Kiyoshi Matsumoto; Shuhei Yamada; Tomoki Kosho
Journal:  Glycobiology       Date:  2018-02-01       Impact factor: 4.313

8.  Osteogenesis imperfecta type III/Ehlers-Danlos overlap syndrome in a Chinese man.

Authors:  Yanqin Lu; Yanzhou Wang; Frank Rauch; Hu Li; Yao Zhang; Naixiang Zhai; Jian Zhang; Xiuzhi Ren; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-02

9.  Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.

Authors:  Sejin Han; Elena Makareeva; Natalia V Kuznetsova; Angela M DeRidder; Mary Beth Sutter; Wolfgang Losert; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

Review 10.  New genes in bone development: what's new in osteogenesis imperfecta.

Authors:  Joan C Marini; Angela R Blissett
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.